Elevated monocyte chemoattractant protein-1 levels following thermal injury precede monocyte recruitment to the wound site and are controlled, in part, by tumor necrosis factor-α

Wound Repair and Regeneration

Volumn 11, Issue 2, 2003, Pages 110-119

  Heinrich, Scott A ^a   Messingham, Kelly A N ^a   Gregory, Meredith S ^a,b   Colantoni, Alessandra ^a   Ferreira, Ahalia M ^a   Dipietro, Luisa A ^a   Kovacs, Elizabeth J ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; THERMAL INJURY; WOUND HEALING;

ANIMALS; BURNS; CHEMOKINE CCL2; CHEMOTAXIS, LEUKOCYTE; FEMALE; MACROPHAGES; MICE; MICE, INBRED BALB C; MONOCYTES; SKIN; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 0037367203     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-475X.2003.11206.x     Document Type: Article

References (66)

1. Burke JF, Quinby WC, Bondoc CC, Cosimi AB, Russell PS, Szyfelbein SK. Immunosuppression and temporary skin transplantation in the treatment of massive third degree burns. Ann Surg 1975;182: 183-97.
2. Shirani KZ, Vaughan GM, Mason AD Jr, Pruitt BA Jr. Update on current therapeutic approaches in burns. Shock 1996;5:4-16.
3. Alexander W, Moncrief JA. Alterations of the immune response following severe thermal injury. Arch Surg 1966;93:75-83.
4. Faunce DE, Gregory MS, Kovacs EJ. Effects of acute ethanol exposure on cellular immune responses in a murine model of thermal injury. J Leukoc Biol 1997;62:733-40.
5. Lederer JA, Rodrick ML, Mannick JA. The effects of injury on the adaptive immune response. Shock 1999;11:153-9.
6. O'Sullivan ST, O'Connor TPF. Immunosuppression following thermal injury: the pathogenesis of immunodysfunction. Br J Plast Surg 1997; 50:615-23.
7. Ramzy PI, Barret JP, Herndon DN. Thermal injury. Crit Care Clin 1999;15:333-52.
8. Sevitt S. A review of the complications of burns, their origin and importance for illness and death. J Trauma 1979;19:358-69.
9. Faunce DE, Gregory MS, Kovacs EJ. Glucocorticoids protect against suppression of T cell responses in a murine model of acute ethanol exposure and thermal injury by regulating IL-6. J Leukoc Biol 1998;64:724-32.
10. Faunce DE, Gregory MS, Kovacs EJ. Acute ethanol exposure prior to thermal injury results in decreased T-cell responses mediated in part by increased production of IL-6. Shock 1998;10:135-40.
11. Gregory MS, Faunce DE, Duffner LA, Kovacs EJ. Gender difference in cell-mediated immunity after thermal injury is mediated, in part, by elevated levels of interleukin-6. J Leukoc Biol 2000;67: 319-26.
12. 2 in male and female mice subjected to thermal injury contributes to the gender difference in immune function: possible role for 15-hydroxyprostaglandin dehydrogenase. Cell Immunol 2000;205:94-102.
13. Kawakami M, Kaneko N, Anada H, Terai C, Okada Y. Measurement of interleukin-6, interleukin-10, and tumor necrosis factor-alpha in tissues and plasma after thermal injury in mice. Surgery 1997;127:440-8.
14. Kupper ST, Deitch EA, Baker CC, Wong W. The human burn wound as a primary source of interleukin-1 activity. Surgery 1986;100: 409-14.
15. Messingham KA, Fontanilla CV, Colantoni A, Duffner LA, Kovacs EJ. Cellular immunity after ethanol exposure and burn injury: dose and time dependence. Alcohol 2000;22:35-44.
16. O'Riordain MG, Collins KH, Pilz M, Saporoschetz IB, Mannick JA, Rodrick ML. Modulation of macrophage hyperactivity improves survival in a burn-sepsis model. Arch Surg 1992;127:152-8.
17. Rodriguez JL, Miller CG, Garner WL, Till GO, Guerrero P, Moore NP, Corridore M, Normolle DP, Smith DJ, Remick DG. Correlation of the local and systemic cytokine response with clinical outcome following thermal injury. J Trauma 1993;34:684-94.
18. RoUins BJ. "Oh no. Not another cytokine." -MCP-1 and respiratory disease. Am J Respir Cell Mol Biol 1999;7:126-7.
19. 2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998;394:894-7.
20. Brieland JK, Jones ML, Flory CM, Miller GR, Warren JS, Phan SH, Fantone JC. Expression of monocyte chemoattractant protein-1 (MCP-1) by rat alveolar macrophages during chronic lung injury. Am J Respir Cell Mol Biol 1993;9:300-5.
21. Capers IVQ, Alexander RW, De Lou P, Leon H, Josiah NW, Ishizaka N, Howard AB, Taylor WR. Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats. Hypertension 1997; 30:1397-402.
22. Frazier-Jessen MR, Mott FJ, Witte PL, Kovacs EJ. Estrogen suppression of connective tissue deposition in a murine model of peritoneal adhesion formation. J Immunol 1996;156:3036-42.
23. Gu L, Okada Y, Clinton SK, Sukhova GK, Libby P, Rollins BJ. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998;2:275-81.
24. Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991;88:1121-7.
25. Yu X, Dluz S, Graves DT, Zhang L, Antoniades HN, Hollander W, Prusty S, Valente AJ, Schwartz CJ, Sonenshein GE. Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates. Proc Natl Acad Sci USA 1992;89:6953-7.
26. DiPietro LA, Polvenni PJ, Rahbe SM, Kovacs EJ. Modulation of JE/MCP-1 expression in dermal wound repair. Am J Pathol 1995;146: 868-75.
27. Gibran NS, Ferguson M, Heimbach DM, Isik FF. Monocyte chemoattractant protein-1 mRNA expression in the human burn wound. J Surg Res 1997;70:1-6.
28. Walker HL, Mason AD Jr. A standard animal burn. J Trauma 1968;8:1049-51.
29. Spector WS. Handbook of biological data. Philadelphia, PA., 1956.
30. Faunce DE, Llanas JN, Patel PJ, Gregory MS, Duffner LA, Kovacs EJ. Neutrophil chemokine production in the skin following scald injury. Burns 1999;25:403-10.
31. Gamelli RL, He LK, Liu H. Marrow granulocyte-macrophage progenitor cell response to burn injury as modified by endotoxin and indomethacin. J Trauma 1994;37:339-46.
32. Kraal G, Rep M, Janse M. Macrophages in T and B cell compartments and other tissue macrophages recognized by monoclonal antibody MOMA-2. An immunohistochemical study. Scand J Immunol 1987;26:653-61.
33. Patel PJ, Faunce DE, Gregory MS, Duffner LA, Kovacs EJ. Elevation in pulmonary neutrophils and prolonged production of pulmonary macrophage inflammatory protein-2 after burn injury with prior alcohol exposure. Am J Respir Cell Mol Biol 1999;20:1229-37.
34. Catania RA, Schwacha MG, Cioffi WG, Bland KI, Chaudry IH. Does uninjured skin release proinflammatory cytokines following trauma and hemorrhage? Arch Surg 1999;134:368-74.
35. Brieland JK, Flory CM, Jones ML, Miller GR, Remick DG, Warren JS, Fantone JC. Regulation of monocyte chemoattractant protein-1 gene expression and secretion in rat pulmonary alveolar macrophages by lipopolysaccharide, tumor necrosis factor-α, and interleukin-1β. Am J Respir Cell Mol Bio 1995;12:104-9.
36. Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, Kunkel SL, North R, Gerard C, Rollins BJ. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 1998;187:601-8.
37. Yamashiro S, Takeya M, Kuratsu J-I, Ushio Y, Takahashi K, Yoshimura T. Intradermal injection of monocyte chemoattractant protein-1 induces emigration and differentiation of blood monocytes in rat skin. Int Arch Allergy Immunol 1998;115:15-23.
38. DiPietro LA, Reintjes MG, Low QE, Levi B, Gamelli RL. Modulation of macrophage recruitment into wounds by monocyte chemoattractant protein-1. Wound Rep Reg; 2001;9:28-33.
39. Driscoll KE. Macrophage inflammatory proteins: biology and role in pulmonary inflammation. Exp Lung Res 1994;20:473-90.
40. Koch AE, Kunkel SL, Harlow LA, Mazarakis DD, Haines GK, Burdick MD, Pope RM, Strieter RM. Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis. J Clin Invest 1994;93:921-8.
41. Lahrtz F, Piali L, Spanaus KS, Seebach J, Fontana A. Chemokines and chemotaxis of leukocytes in infectious meningitis. J Neuroimmunol 1998;85:33-43.
42. Low QE, Drugea IA, Duffner LA, Quinn DG, Cook DN, Rollins BJ, Kovacs EJ, DiPietro LA. Wound healing in MIP-1alpha(-/-) and MCP1(-/-) mice. Am J Pathol 2001;159:457-63.
43. DiPietro LA, Burdick M, Low QE, Kunkel SL, Strieter RM. MIP-1alpha as a critical macrophage chemoattractant in murine wound repair. J Clin Invest 1998;101:1693-8.
44. Yu X, Barnhill RL, Graves DT. Expression of monocyte chemoattractant protein-1 in delayed type hypersensitivity reactions in the skin. Lab Invest 1994;71:226-35.
45. Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 1990;87:5134-8.
46. Taubman MB, Rollins BJ, Poon M, Marmur J, Green RS, Berk BC, Nadal-Ginard B. JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells. Circ Res 1992;70:314-25.
47. Drost AC, Burleson DG, Cioffi WG Jr, Jordan BS, Mason AD Jr, Pruitt BA Jr. Plasma cytokines following thermal injury and their relationship with patient mortality, burn size, and time postburn. J Trauma 1993;35:335-9.
48. Drost AC, Burleson DG, Cioffi WG Jr, Jordan BS, Mason AD Jr, Pruitt BA Jr. Plasma cytokines after thermal injury and their relationship to infection. Ann Surg 1993b;218:74-8.
49. Fahey TJ III, Sherry B, Tracey KJ, van Deventer S, Jones WG II, Minei JP, Morgello S, Shires GT, Cerami A. Cytokine production in a model of wound healing: the appearance of MIP-1, MIP-2, cachectin/TNF and IL-1. Cytokine 1990;2:92-9.
50. Rollins BJ, Yoshimura T, Leonard EJ, Pober JS. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol 1990;136:1229-33.
51. Sica A, Wang JM, Colotta F, Dejana E, Mantovani A, Oppenheim JJ, Larsen CG, Zachariae COC, Matsushima K. Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J Immunol 1990;144:3034-8.
52. Strieter RM, Wiggins R, Phan SH, Wharmm BL, Showell HJ, Remick DG, Chensue SW, Kunkel SL. Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells. Biochem Biophy Res Commun 1989;162:694-700.
53. Standiford TJ, Kunkel SL, Phan SH, Rollins BJ, Strieter RM. Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J Biol Chem 1991;266:9912-8.
54. Garner WL, Rodriguez JL, Miller CG, Till GO, Rees RS, Smith J, Remick DG. Acute skin injury releases neutrophil chemoattractants. Surgery 1994;116:42-8.
55. Feiken E, Romer J, Eriksen J, Lund LR. Neutrophils express tumor necrosis factor-α during mouse wound repair. J Invest Dermatol 1995;105:120-3.
56. Hubner G, Brauchle M, Smola H, Madlener M, Fassler R, Werner S. Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine 1996; 8:548-56.
57. Kovacs EJ. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today 1991;12:17-23.
58. Kovacs EJ, DiPietro LA. Fibrogenic cytokines and connective tissue production. FASEB J 1994;8:854-61.
59. McCourt M, Wang JH, Sookhai S, Redmond HP. Proinflammatory mediators stimulate neutrophil-directed angiogenesis. Arch Surg 1999;134:1325-31.
60. Roesel JF, Nanney LB. Assessment of differential cytokine effects on agiogenesis using an in vivo model of cutaneous wound repair. J Surg Res 1995;58:449-59.
61. Tracey KJ. Tumour necrosis factor-alpha. In: Thomson WA, editor. The cytokine handbook. 2nd ed. London: Academic Press, 1994:289-304.
62. Marano MA, Fong Y, Moldawer LL, Wei H, Calvano SE, Tracey KJ, Barie PS, Manogue K, Cerami A, Shires GT, Lowry S. Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet 1990;170:32-8.
63. Molloy RG, O'Riordain M, Holzheimer R, Nestor M, Collins K, Mannick JA, Rodrick ML. Mechanism of increased tumor necrosis factor production after thermal injury. J Immunol 1993;151:2142-9.
64. 2 production by trauma patients' monocytes. Arch Surg 1990;125:29-35.
65. O'Riordain MG, O'Riordain DS, Molloy RG, Mannick JA, Rodrick ML. Dosage and timing of anti-TNF-α antibody treatment determine its effect on resistance to sepsis after injury. J Surg Res 1996; 64:95-101.
66. Natanson C, Hoffman WD, Suffredini AF, Eichacker PQ, Danner RL. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 1994;120:771-83.